MarketPeel
Insider Trading Intelligence
HC

Hao-yuan Chuang

BLTE
CHIEF FINANCIAL OFFICER · BELITE BIO, INC · CIK 0001992008
FILING MIX · LIFETIME33%/67%
BUYS
2
SELLS
4
TOTAL VALUE
$1.13M
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
205,264
AVG SELL PX
$181.50
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 20 pending
Forward-return performance of every backtestable P/S trade by Hao-yuan Chuang, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+100.00%-12.76%+3.20%-15.96%-15.96%
14d4+100.00%-9.23%+4.20%-13.43%-13.43%
30d4+100.00%-14.51%+8.49%-23.00%-23.00%
60d4(4 pending)
90d4(4 pending)
180d4(4 pending)
1y4(4 pending)
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BLTE · 205,264 shares · as of Apr 21, 2026
072,434144,868217,302289,736SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 2 buys / 4 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
BLTE
BELITE BIO, INC
PURCHASE
Chief Financial Officer
10,000205,264Apr 21, 2026Apr 23, 2026
BLTE
BELITE BIO, INC
SALE10b5-1
10b5-1 plan
291$183.08$53.3K93,800Apr 9, 2026Apr 13, 2026
BLTE
BELITE BIO, INC
SALE10b5-1
10b5-1 plan
1,909$182.58$348.5K94,091Apr 9, 2026Apr 13, 2026
BLTE
BELITE BIO, INC
SALE10b5-1
10b5-1 plan
2,000$181.40$362.8K96,000Apr 9, 2026Apr 13, 2026
BLTE
BELITE BIO, INC
SALE10b5-1
10b5-1 plan
2,000$180.35$360.7K98,000Apr 9, 2026Apr 13, 2026
BLTE
BELITE BIO, INC
PURCHASEGRANT
Stock grant
144,868289,736Mar 31, 2026Apr 2, 2026
Other insiders · BLTE
Loading peer insiders…
About this filer
CIK 0001992008
ROLE
Chief Financial Officer
PRIMARY
BLTE
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0001992008DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback